Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Risk of prostate cancer death in long-term users of warfarin: a population-based case-control study.

Tagalakis V, Tamim H, Blostein M, Hanley JA, Kahn SR.

Cancer Causes Control. 2013 Jun;24(6):1079-85. doi: 10.1007/s10552-013-0185-1. Epub 2013 Mar 15.

PMID:
23494728
2.

Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study.

Tagalakis V, Tamim H, Blostein M, Collet JP, Hanley JA, Kahn SR.

Lancet Oncol. 2007 May;8(5):395-402.

PMID:
17466896
3.

The effect of warfarin use on clinical stage and histological grade of prostate cancer.

Tagalakis V, Tamim H.

Pharmacoepidemiol Drug Saf. 2010 May;19(5):436-9. doi: 10.1002/pds.1943.

PMID:
20437456
4.

Validating a method that deals with missing drug information in the Saskatchewan Drug Plan database.

Tamim HM, Tagalakis V.

Pharmacoepidemiol Drug Saf. 2009 Feb;18(2):140-6. doi: 10.1002/pds.1692.

PMID:
19090502
5.

Molecular markers and death from prostate cancer.

Concato J, Jain D, Uchio E, Risch H, Li WW, Wells CK.

Ann Intern Med. 2009 May 5;150(9):595-603.

PMID:
19414838
6.

Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM).

Russo AL, Chen MH, Aizer AA, Hattangadi JA, D'Amico AV.

BJU Int. 2012 Oct;110(7):973-9. doi: 10.1111/j.1464-410X.2012.11470.x.

7.

Vasectomy and prostate cancer: a case-control study in India.

Platz EA, Yeole BB, Cho E, Jussawalla DJ, Giovannucci E, Ascherio A.

Int J Epidemiol. 1997 Oct;26(5):933-8.

PMID:
9363512
8.

Antidepressants and risk of prostate cancer: a nested case-control study.

Tamim HM, Mahmud S, Hanley JA, Boivin JF, Stang MR, Collet JP.

Prostate Cancer Prostatic Dis. 2008;11(1):53-60. Epub 2007 Aug 7.

PMID:
17684479
9.

Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.

Aizer AA, Chen MH, Hattangadi J, D'Amico AV.

BJU Int. 2014 Jan;113(1):43-50. doi: 10.1111/j.1464-410X.2012.11789.x. Epub 2013 Mar 8.

10.

Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.

van Leeuwen PJ, Otto SJ, Kranse R, Roobol MJ, Bul M, Zhu X, de Koning H, Schröder FH.

BJU Int. 2012 Jul;110(2):188-94. doi: 10.1111/j.1464-410X.2011.10811.x. Epub 2012 Jan 30.

11.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
12.

Vasectomy and prostate cancer: a case-control study in a health maintenance organization.

Zhu K, Stanford JL, Daling JR, McKnight B, Stergachis A, Brawer MK, Weiss NS.

Am J Epidemiol. 1996 Oct 15;144(8):717-22.

PMID:
8857819
13.

Long-term survival in a Swedish population-based cohort of men with prostate cancer.

Sandblom G, Dufmats M, Varenhorst E.

Urology. 2000 Sep 1;56(3):442-7.

PMID:
10962312
14.

Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.

Hattangadi JA, Chen MH, D'Amico AV.

BJU Int. 2012 Dec;110(11):1636-41. doi: 10.1111/j.1464-410X.2012.11354.x. Epub 2012 Jul 3.

15.

Obesity, adipokines, and prostate cancer in a prospective population-based study.

Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Troyer D, Hernandez J, Lynch S, Leach RJ, Thompson IM.

Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1331-5.

16.

Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.

Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, Platz EA, Sutcliffe S, Fall K, Kurth T, Ma J, Stampfer MJ, Mucci LA.

J Natl Cancer Inst. 2009 Oct 21;101(20):1406-11. doi: 10.1093/jnci/djp306. Epub 2009 Sep 9.

17.

Short- and long-term mortality with localized prostate cancer.

Merglen A, Schmidlin F, Fioretta G, Verkooijen HM, Rapiti E, Zanetti R, Miralbell R, Bouchardy C.

Arch Intern Med. 2007 Oct 8;167(18):1944-50.

PMID:
17923593
18.

Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men.

Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR.

Cancer Causes Control. 2008 Feb;19(1):25-31. Epub 2007 Sep 30.

PMID:
17906959
19.

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1262-9.

20.

Association between metformin use and risk of prostate cancer and its grade.

Margel D, Urbach D, Lipscombe LL, Bell CM, Kulkarni G, Austin PC, Fleshner N.

J Natl Cancer Inst. 2013 Aug 7;105(15):1123-31. doi: 10.1093/jnci/djt170. Epub 2013 Jul 13.

PMID:
23853056

Supplemental Content

Support Center